Loading...
•
Dec 31, 2024
Twist Bioscience Q1 2025 Earnings Report
Reported record revenue and improved gross margin.
Key Takeaways
Twist Bioscience reported a strong start to fiscal year 2025, achieving record revenue of $88.7 million, a 24% increase compared to the same period last year, and a gross margin of 48.3%, which is a 7.8 margin points improvement year-over-year.
Total revenue for the first quarter of fiscal 2025 grew to $88.7 million, a 24% increase compared to the same period in fiscal 2024.
Gross margin for the first quarter of fiscal 2025 increased to 48.3% compared to 40.5% for the same period in fiscal 2024.
Net loss attributable to common stockholders for the first quarter of fiscal 2025 was $31.6 million, or $0.53 per share, compared to $43.0 million, or $0.75 per share, for the same period of fiscal 2024.
As of December 31, 2024, the company had $270.8 million in cash, cash equivalents and short-term investments.
Revenue by Segment
Forward Guidance
Twist Bioscience expects revenue in the range of $372 million to $379 million for full year fiscal 2025 and expects gross margin over 50% for 4QFY25.
Positive Outlook
- Total revenue to be in the range of $372 million to $379 million compared to the previous guidance of $367 million to $377 million, indicating growth of 19 to 21 percent year over year
- SynBio revenue of $144 million to $147 million, compared to previous guidance of $142 million to $146 million, growth of 17 to 18 percent
- NGS revenue of $205 million to $209 million, compared to previous guidance of $204 million to $209 million, growth of 21 to 24 percent
- Biopharma revenue of $23 million, compared to previous guidance of $21 million to $22 million, growth of 13 percent
- Gross margin is projected to be approximately 49% for fiscal 2025 with quarterly sequential improvements, compared to previous guidance of 48% and 4QFY25 gross margin is projected to be over 50%
Challenges Ahead
- Adjusted EBITDA of approximately $(55) million to $(60) million for fiscal 2025 compared to previous guidance of $(60) million to $(65) million
- Total revenue of approximately $91 million to $93 million for the second quarter
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...